Compound ID | 1444
Synonym(s): Ceftaroline fosamil
Class: Beta-lactam (cephalosporin)
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Anti-MRSA and Enterobacteriaceae; indicated for acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia |
| Institute where first reported: | Forest Laboratories, USA/ AbbVie/ Allergan/ Cerexa Inc. |
| Year first mentioned: | 2008 |
| Highest development stage: | Approved by FDA in 2010; Approved for pediatric use in 2016 |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9852981 |
| Guide to Pharmacology: | ceftaroline fosamil |
| Citations: |
|